Literature DB >> 3389358

Sulfadiazine-associated obstructive nephropathy occurring in a patient with the acquired immunodeficiency syndrome.

L G Carbone1, B Bendixen, G B Appel.   

Abstract

A 45-year-old man with the Acquired Immunodeficiency Syndrome (AIDS) and CNS toxoplasmosis presented with acute renal failure, hematuria, and renal colic shortly after starting treatment with sulfadiazine. Ultrasound examination of his kidneys was suggestive of intraparenchymal crystallization of sulfadiazine. His renal failure and ultrasound findings rapidly resolved with alkaline hydration. On rechallenge with sulfadiazine, he again developed renal insufficiency and ultrasonic findings consistent with stones. The use of sulfadiazine in the treatment of CNS toxoplasmosis in AIDS patients should be monitored carefully with the recognition that this form of crystalline-induced acute renal failure can occur in a dehydrated patient.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3389358     DOI: 10.1016/s0272-6386(88)80076-3

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  7 in total

Review 1.  Drug-Induced Kidney Stones and Crystalline Nephropathy: Pathophysiology, Prevention and Treatment.

Authors:  Michel Daudon; Vincent Frochot; Dominique Bazin; Paul Jungers
Journal:  Drugs       Date:  2018-02       Impact factor: 9.546

2.  Trovafloxacin is active against Toxoplasma gondii.

Authors:  A A Khan; T Slifer; F G Araujo; J S Remington
Journal:  Antimicrob Agents Chemother       Date:  1996-08       Impact factor: 5.191

Review 3.  Sulfadiazine-induced nephrolithiasis in children.

Authors:  Charlotte Catalano-Pons; Sophie Bargy; Deborah Schlecht; Marie-Dominique Tabone; George Deschênes; Albert Bensman; Tim Ulinski
Journal:  Pediatr Nephrol       Date:  2004-06-17       Impact factor: 3.714

4.  Meeting report of the "Symposium on kidney stones and mineral metabolism: calcium kidney stones in 2017".

Authors:  Agnieszka Pozdzik; Naim Maalouf; Emmanuel Letavernier; Isabelle Brocheriou; Jean-Jacques Body; Benjamin Vervaet; Carl Van Haute; Johanna Noels; Romy Gadisseur; Vincent Castiglione; Frédéric Cotton; Giovanni Gambaro; Michel Daudon; Khashayar Sakhaee
Journal:  J Nephrol       Date:  2019-01-24       Impact factor: 3.902

Review 5.  Current recommendations and future prospects in the treatment of toxoplasmosis.

Authors:  R E McCabe; S Oster
Journal:  Drugs       Date:  1989-12       Impact factor: 9.546

Review 6.  Kidney disease in children and adolescents with perinatal HIV-1 infection.

Authors:  Rajendra Bhimma; Murli Udharam Purswani; Udai Kala
Journal:  J Int AIDS Soc       Date:  2013-06-18       Impact factor: 5.396

7.  Nephrotoxicity of HAART.

Authors:  Robert Kalyesubula; Mark A Perazella
Journal:  AIDS Res Treat       Date:  2011-08-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.